Crescent Bioresearch reports DSIP lot below 5 EU per vial endotoxin
The certificate separates lysate sensitivity of 0.05 EU/mL from the endotoxin result, two figures the supplier says are routinely conflated on vendor reports.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 23 09:00 ETSource: FinancialContent
The wire
- 01BTLabs tested DSIP 15 mg lot CBR-DSP-260403-001 on Sept. 24, 2026 by kinetic turbidimetric LAL under USP Chapter 85, returning less than 5 EU per vial against a 350 EU limit, under 0.33 EU per milligram.
- 02Sleep-peptide buyers often see only a sensitivity figure and the word pass on gray-market certificates, which gives no actual measurement of the vial.
- 03The material is sold for laboratory research only, the report is supplier-published, and DSIP has no approved human indication or FDA-reviewed dosing.
From the source
Read at financialcontent.comCrescent Bioresearch Publishes DSIP Endotoxin Report: Below 5 EU per Vial at 0.05 EU/mL Sensitivity
The DSIP endotoxin report for lot CBR-DSP-260403-001 lists a lysate sensitivity of 0.05 EU/mL and a result of less than 5 EU per vial. The first figure describes the test. The second describes the vial.
